Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by GWAA Polish Study Group
Exenatide Twice Daily Versus Insulin Glargine for the Treatment of Type 2 Diabetes in Poland — Subgroup Data From a Randomised Multinational Trial GWAA
Endokrynologia Polska
Endocrinology
Metabolism
Diabetes
Related publications
Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Cost-Effectiveness Analysis of Exenatide Twice Daily (BID) Versus Insulin Glargine Once Daily (QD) as Add-On Therapy in Chinese Patients With Type 2 Diabetes Mellitus Inadequately Controlled by Oral Therapies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Assessing Insulin Effectiveness at the End of the Day: Once-Daily Versus Twice-Daily Insulin Glargine Injection
Journal of Diabetes Mellitus
Achieve Control: A Pragmatic Clinical Trial of Insulin Glargine 300 U/mL Versus Other Basal Insulins in Insulin-Naïve Patients With Type 2 Diabetes
Postgraduate Medicine
Medicine
Insulin Glargine/Lixisenatide in Type 2 Diabetes: A Profile of Its Use
Drugs and Therapy Perspectives
Pharmacology
The Comparative Study With Lixisenatide /Glargine Combination Therapy Versus Twice-Daily Premixed Insulin Therapy/DPP-4 Inhibitor on Glycemic Variability, and Feeding Behavior in Obese Patients With Type 2 Diabetes Mellitus
Health and Primary Care
Use of Insulin Glargine 100 U/mL for the Treatment of Type 2 Diabetes Mellitus in East Asians: A Review
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Efficacy and Safety of Exenatide Versus Insulin in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
International Journal of Management, Economics and Social Sciences
Insulin Four Times Daily Is Better Than Twice Daily for Diabetes in Pregnancy
BMJ